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ABSTRACT
Objective: This study was aimed to inhibit the sulfite reductase using naturally obtained secondary metabolites of common plants Azadirachta indica 
and Lawsonia inermis.
Methods: The active ingredients of neem and henna were selected and the.sdf files of these were downloaded from PubChem database. Converted 
the.sdf files to.pdb files with the help of OPENBABEL software which is prerequisite to dock. The three-dimensional structure was incurred from the 
template of homology of sulfite reductase using MODELLAR software version 9.0. Docking of sulfite reductase with the ligands was performed using 
iGEMDOCK and Autodock Vina softwares. The physicochemical, pharmacokinetic, drug-likeness, lead-likeness, and toxicological properties were 
obtained by SWISSADME and admetSAR online tools.
Results: The active ingredients show an excellent affinity with the sulfite reductase which obtained was tabulated and the significant properties of a 
ligand were showing that these can be an investigational new drug entity.
Conclusion: In this research, it can concluded that the secondary metabolites obtained from plants were inhibiting the induction of sulfite reductase 
thereby inhibiting Sulfite Assimilation Pathway leads to commove the amino acid metabolism of organism which shows unique in fungi.
Keywords: Sulfite reductase, Sulfate assimilation pathway, Azadirachta indica, Lawsonia inermis, OPENBABEL, iGEMDOCK, Autodock Vina, 
SwissADMET, admetSAR.
INTRODUCTION
Fungi are eukaryotic organisms of non-motile in nature with rigid cell 
wall and are around 80,000 species have been known but only about 
400 species are clinically important, and about 50 are responsible for 
90% of the infections of human beings, and other animals. Mycology is 
the branch of science which deals with the fungal organisms. Mycoses 
are a variety of common environmental and physiological conditions 
than can cause fungal diseases. Most pathogenic fungi are exogenous, 
their natural habitats being water, soil, and organic debris. The mycoses 
with the highest incidence are candidiasis and dermatophytosis which 
were caused by fungi. Dermatophytosis caused by fungal organisms is 
a ubiquitous problem and seems to be as the important cause for the 
morbidity [1].
The importance of medicinal plants in treating diseases is tailor-made 
from centuries as these contain components of therapeutic value [2]. 
Around 250,000 species of higher plants were estimated of their 
pharmacological activities and not proven completely. The antimicrobial 
properties of certain Indian medicinal plants were reported based on 
folklore information [3] and a few attempts were made on inhibitory 
activity against certain pathogenic bacteria and fungi [4].
Sulfite reductase is an enzyme involved in the sulfate assimilation 
pathway with EC no: 1.8.1.2 that influences the sulfur metabolism [5]. 
The sulfate assimilation pathway is not essential for the fungi as 
fungal organisms can utilize by the availability of methionine from 
environment. In the process of synthesis of cysteine and methionine 
in fungi requires cellular uptake and reduction of sulfate to sulfide 
which is an assimilatory in nature [6]. In Saccharomyces cerevisiae, the 
sulfate assimilation pathway is considered as a part of the methionine 
metabolism. Some studies show that the genes implicated in different 
steps of this pathway can meet their auxotrophic requirement by 
methionine. In yeast, no monogenic mutant has yet been found and to 
be a strict cysteine auxotroph. A few years ago, about 100 methionine 
auxotrophs have been classified in to different complementation 
group [6]. The sulfate assimilation pathway is the mechanism involved 
the interference of amino acid transport and cellular regulation of amino 
acid metabolism in the fungal organism [7]. Inhibition of induction of 
sulfite reductase enzyme of sulfate assimilation pathway was found to be 
the major cause of SA inhibition [8]. The inhibition of sulfite reductase 
may leads to repression of transcription of genes and interference of 
post-translational steps for expression of sulfite reductase activity [8].
Azadirachta indica is commonly called as neem which is an indigenous 
plant with a multitudinous uses because of medicinal properties [9,10]. 
The phytochemical compounds of A. indica can be alkaloids, flavonoids, 
triterpenoids, phenolic compounds, carotenoids, steroids, and ketones, 
biologically most active compound is Azadirachtin which is a mixture of 
seven isomeric compounds labeled as azadirachtin A-G and azadirachtin 
E [11,12]. Biologically important secondary metabolites from various 
parts of the plant were azadirachtin, meliacin, gedunin, nimbidin, 
nimbolides, salanin, nimbin, valassin, meliacin makes the bitter taste 
of neem oil, and the seeds contain tignic acid which is responsible 
for distinctive odor [13]. Neem kernels contain 30–50% of oil mainly 
used by the soap, pesticide, and pharmaceutical industries and also 
contain many active ingredients which are together called triterpene or 
limonoids [14]. The four best limonoid compounds are: Azadirachtin, 
Salannin, Meliantriol, and Nimbin. Limonoids contain insecticidal and 
pesticidal activity [15].
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i7.26695
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Lawsonia inermis is commonly called as henna which is having very 
potent anti-microbial properties. The phytochemical investigation of 
henna over the past decades led to the isolation of several important 
active ingredients such as b-sitosterol glucosides, flavonoids, quinoids, 
naphthalene derivatives, triterpenoids, coumarins, xanthones, and 
phenolic glycosides [16]. The isolated compounds and different henna 
extracts were evaluated for their antibacterial, antiviral, antimycotic, 
and antiparasitic activities [17].
In our continuous effort to discover a natural agent as a drug which acts 
as a novel potential drug target to reduce untoward effects, we selected 
the secondary metabolites of A. indica and L. inermis. These metabolites 
are to be tested for their potential to inhibit sulfite reductase which 
plays a role in amino acid metabolism of fungal organism called sulfate 
assimilation pathway.
METHODS
Preparation of Protein by homology modeling
Sulfite reductase is an enzyme that involves in sulfate assimilation 
pathway which is a vital for the metabolism of various sulfur containing 
metabolic reactions. The three-dimensional (3D) structure of this 
enzyme is not available in RCSB database. The primary structure of 
sulfite reductase (Uniprotkb accession no: A0A0J1ATI0) was retrieved 
in FASTA format from UniprotKB database [18]. The homology template 
of sulfite reductase (template RCSB accession code: 1MI3) was obtained 
from RCSB protein data bank database. The homology model was 
performed using MODELLAR software version 9.0 with Easy modeller 
as GUI. The query sequence of the sulfite reductase was aligned with 
the template sequence to generate 3D structure. The generated 3D 
structure of the protein was validated by Ramachandran plot.
Preparation of ligand
Azadirachtin, nimbin, and nimonol were the most essential secondary 
metabolites selected from A. indica and alpha-ionone, beta-ionone, 
lawsone, lawsoniaside, scopoletin, and stigmasterol were selected 
from L. inermis. These ligands were obtained from PubChem database, 
as SDF format. The SDF file was converted into PDB file with software 
OPENBABEL. The physiochemical, pharmacokinetic, toxicity, drug-
likeness, and lead-likeness properties of these ligands were evaluated 
by free web tool SwissADME [19], and admetSAR [20].
Protein–ligand docking
Initially rough docking was performed between the protein and each 
ligand with iGEMDOCK 2.0 with a population size of 150 and 70 
generations, set as default. The protein–ligand docking was performed 
by Autodock Vina [21], an interactive molecular graphics program 
for calculating and displaying feasible docking modes of protein and 
ligands and were presented hierarchically based on the binding affinity. 
The best docked protein–ligand interaction was visualized using 
PyMOL [22] which is an open-source molecular visualization system.
RESULTS
Homology modeling and protein validation
The 3D structure of sulfite reductase was obtained by homology 
modeling and was validated by Ramachandran plot. Ramachandran 
plot/diagram, was developed by Ramachandran et al. [23], in 1963, 
is helpful to visualize energetically allowed regions for backbone [24] 
dihedral angles ψ(psi) against φ (phi) of amino acid residues in protein 
structure which was shown in Fig. 1. The Ramachandran plot showed 
that the modeled protein contains 93.3% of amino acid residues in the 
favored region, 5.3% in allowed region, and 1.4% in amino acid residues 
in disallowed region.
Protein-ligand docking
The sulfite reductase was docked with a number of small molecules 
known as secondary metabolites of A. indica and L. inermis. The docked 
poses of the sulfite reductase with all the ligands were shown in Fig. 2. 
The energy values, Van der Waals force (VDW), and hydrogen bond 
(H-bond) between protein and ligand were derived by rough docking 
with iGEMDOCK and Autodock Vina was presented in Table 1. The 
energy values obtained by sulphite reductase with compounds of A. 
indica and L. inermis was excellent, azadirachtin was -168.194 stands 
Fig. 1: Ramachandran plot shows the number of amino acids that are favored, allowed, and disallowed in model protein sulfite reductase
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maximum in A. indica and scopoletin as −94.5167 stands maximum 
in L. inermis with iGEMDOCK and −14.4 for azadirachtin in A.indica 
secondary metabolites and – 9.7 for lawsoniaside in L. inermis secondary 
metabolites with Autodock Vina. The VDW between them was more for 
azadirachtin and alpha-ionone as −138.575 and −82.484, respectively.
The physicochemical properties such as molecular weight, heavy 
atoms, Fraction Csp3, rotatable bonds, H-bond acceptors, H-bond 
donors, molecular refractivity, and topological polar surface area 
(TPSA) of all the ligands were presented in Table 2 on which the 
molecular weight, number of atoms, fraction Csp3, number of rotatable 
bonds, molar refractivity, and TPSA, for azadirachtin, nimbin, and 
lawsoniaside observes as these were not following the Lipinski rule of 
five [25,26] and drug-likeliness properties as the molecular weight is 
more than 500. The number of atoms required for drug-likeliness [27] 
should be in a range of 20–70 atoms which were obeyed by all selected 
secondary metabolites. The hydrogen bond acceptors for azadirachtin 
and lawsoniaside were above 10 which states these are not following 
Lipinski rule. Fraction Csp3 [19] is the ratio of sp3 hybridized carbons 
over the total carbon count of the molecule which was not obeyed by 
lawsone and scopoletin as it should be at least 0.25. Molar refractivity 
is more than 130 for azadirachtin and nimbin that these were not 
Fig. 2: The picture showing the docking poses of sulfite reductase with all ligands (secondary metabolites of Azadirachta indica and 
Lawsonia inermis)
Table 1: The results of rough docking and accurate docking performed with a software iGEMDOCK and Autodock Vina between the drug 
targets and ligands
S no. Drug targets or 
protein with ligand
Rough docking energy values with iGEMDOCK Binding affinity with Autodock Vina
Total Energy  
Kcal/mol
VDW H-bond Elec Aver Con Pair Energy Kcal/mol RMSD/UB RMSD/LB
1 Sulfite reductase + 
azadirachtin
−168.194 −138.575 −29.619 0 26.7647 −14.4 0 0
2 Sulfite reductase + 
nimbin
−143.362 −136.408 −6.954 0 19.8718 −13.4 0 0
3 Sulfite reductase + 
nimonol
−128.922 −125.422 −3.5 0 23.1212 −13.3 0 0
4 Sulfite reductase + 
alpha-ionone
−84.9848 −82.484 −2.5 0 34.4286 −7.1 0 0
5 Sulfite reductase + 
beta-ionone
−83.9837 −80.483 −3.5 0 33.4286 −7.2 0 0
6 Sulfite reductase + 
lawsone
−90.0447 −67.1 −22.944 0 33.6923 −7.8 0 0
7 Sulfite reductase + 
lawsoniaside
104.201 128.893 −24.692 0 18.9714 −9.7 0 0
8 Sulfite reductase + 
scopoletin
−94.5167 −74.858 −19.658 0 33.5714 −7.2 0 0
9 Sulfite reductase + 
stigmasterol
−39.2956 −39.295 0 0 10.8 −8.9 0 0
VDW: Van der Waals force, H-bond: Hydrogen bond, RMSD: Root mean square deviation
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following drug-likeliness. The TPSA is also more than 140 angstroms 
squared for azadirachtin and lawsoniaside which tends to be likely 
poor permeability between cells [28]. The nimonol, alpha-ionone, beta-
ionone, lawsone, scopoletin, and stigmasterol TPSA are <90 angstroms 
squared depicts as penetratable the blood brain barrier (BBB) [29].
Table 3 presents the pharmacokinetic property of secondary metabolites 
of A. indica and L. inermis, implies as alpha-ionone is more hydrophilic 
with -1.7995 and nimbin, stigmasterol, and nimonol are less aqueous 
soluble with -4.4552, -4.7027, and -5.0718 respectively. As the cell 
permeability is proportional to Caco-2 results, the lawsoniside is less 
permeable and alpha-ionone was more permeable. Alpha-ionone, beta-
ionone, and stigmasterol were localized to lysosomes and others were 
to mitochondria. The azadirachtin, lawsoniaside, and stigmasterol 
were poorly absorbs through gastrointestinal system. Alpha-ionone, 
beta-ionone, lawsone, and scopoletin show permeability to BBB. 
The azadirachtin and nimonol were the substrates for efflux pump 
called P-glycoprotein. All the ligands were not influencing cytochrome 
P450 (CYP) isoenzymes which predict as null drug interactions and 
no alteration in titration of dose except scopoletin which inhibits 
CYP4501A2. All the ligands have an excellent permeability through skin.
Table 4 describes the drug-likeliness and lead-likeliness of secondary 
metabolites of A. indica and L. inermis. The nimonol, alpha-ionone, beta-
ionone, lawsone, and scopoletin follows the Lipinski’s rule of 5 as well 
as Ghose rule [27] and others were violating. Veber rule [30] states as 
rotatable bonds need to be ≤10 and TPSA need to be ≤140 was followed 
by all ligands except azadirachtin and lawsoniaside. Egan’s filter [31] 
was followed by all except azadirachtin, lawsoniaside, and stigmasterol. 
Most of the compounds don’t obey the Muegge’s filter [32] except 
nimbin and nimonol. The bioavailability score [33] for these ligands 
were good as these ligands’ probability for a new drug was at least 
10% oral bioavailability in rodents. The lead-likeliness for these ligands 
was followed for pains filter [34] except for lawsone, 3 violations 
were observed for Brenk filter [35] and for lead-likeness there was 1 
violation for beta-ionone, lawsone, lawsoniaside, and scopoletin, and 
others were 2 violations. The synthetic accessibility was very difficult 
for azadirachtin being 8.1 and very easy for lawsone being 2.46 followed 
by scopoletin.
Table 5 depicts the toxicity profile of the secondary metabolites 
of A. indica and L. inermis which can be assumed as non-toxic as 
these were negative for cardiotoxicity as these does not cause an 
efflux of potassium by human ether-a-go-go-related gene protein 
blockade. Negative in AMES mutagenicity test portrayed as negative 
teratogenicity, fetotoxicity, and fetal malformations. All the compounds 
were categorized as non-carcinogens, and acute oral toxicity was stated 
as Category I, i.e., lethal dose 50 value is ≤50 mg/kg. The rat acute 
toxicity was also in the lower limits for all the ligands.
DISCUSSION
The infections caused by the fungal organisms become a threat and 
challenging to the medical fraternity as they are increasing day by day 
due to opportunistic infections and invasive systemic infections. It is 
the time to expose for a new drug target and new drugs to inhibit the 
growth of fungi. In this study, we selected sulfite reductase as a new 
drug target and the secondary metabolites as drugs which hamper 
the activity of the enzyme to impair the metabolic function of fungi. 
A study by Aoki et al. [36] observed that azoxybacillin, isolated by 
B. Cereus with broad spectrum of antifungal activity by interfering 
with the regulation of expression of sulfite reductase activity. In 
another study by Jorge Amich et al. [37], methionine synthase which 
is a part of sulfur assimilation pathway is essential for A. fumigatus 
virulence observes as the biosynthetic route for the proteinogenic 
amino acid as a potential antifungal target to inhibit the growth. In 
research by Mendoza-Cózatl et al. [38], sulfate assimilation reduction 
and GSH metabolism were regulated with cadmium intoxication of 
yeast, plants, and protists. In a study by Mondall et al. [39], alcoholic 
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and the triterpenoids [40] such as azadirachtin, nimbin, and nimonol 
are the ingredients that show fungicidal activity. According to Dubey 
and Kumar [41], azadirachtin shows an excellent fungicidal action as 
it possesses equally as mancozeb and bavistin. In a study conducted 
by Mahmoud et al. [42], aqueous and organic extracts of neem leaves 
showed their inhibitory effect against the pathogenic fungi. In this 
same study, the mixture of fractions eluted by high-performance 
liquid chromatography was more effective than the pure nimonol 
may be because combination exhibits synergism. According to 
Suleiman and Mohamed [43], ethanol and petroleum ether extracts of 
L. inermis (Henna) revealed antifungal activity against superficial and 
systemic infections. A research by Sharma et al. [44] reported that the 
sensitivity of dermatophytes with henna was robust in Trichophyton 
mentagrophytes, Trichophyton rubrum, Trichophyton tonsurans, 
Trichophyton violaceum, Trichophyton verrucosum, Trichophyton 
schoenleinii, Epidermophyton floccosum, Microsporum ferrugineum, 
Microsporum canis, and Sporotrichum schenckii. A study by Raveesha 
et al. [45] showed that aqueous extract of L. inermis and 10 more other 
plants has observed significant antifungal activity against Aspergillus 
species. Another research by Amal Nawasrah et al. [46] showed that 
addition of henna extract to acrylic resin denture shows the inhibition 
of the growth of Candida albicans in dentures. This study shows that 
sulfite reductase inhibition shackles the sulfate assimilation pathway 
which is essential for fungal survival with the secondary metabolites 
of A. indica and L. inermis.
CONCLUSION
Inhibition of sulfite reductase enzyme of sulfate assimilation 
pathway with the help of small molecules of secondary metabolites of 
certain plants such as A. indica and L. inermis may lead to repression 
of certain genes of sulfite reductase activity and post-translational 
steps of expression of sulfite reductase which can be a new drug 
target and the secondary metabolites can be an investigational new 
drugs.
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